Atara Biotherapeutics Inc (ATRA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATRA Annual Balance Sheets →
Looking at balance sheet data from Atara Biotherapeutics Inc through Jun 30 2025 provides insight into Jun 30 2026's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent9.90
Short-term Investments, Total0.00
Cash & Short-term Investments9.00
Accounts receivable0.32
Other Current Assets0.00
Total Current Assets13.53
Equipment/Property/Plant Net0.04
Other Assets, Noncurrent10.77
Restricted Cash Current-
Total Assets21.02
Liabilities
Accounts Payable, Current AC0.82
Employee-related Liabilities, Current AC2.16
Other Liabilities, Current3.87
Total Current Liabilities6.85
Capital Lease and Other0.10
Total Long-term Debt0.10
Financial Instruments, Insurance, Noncurrent0.77
Other liabilities, Noncurrent50.31
Accrued Research And Development Expenses Current0.04
Operating Lease Liability Noncurrent9.08
Total Liabilities58.02
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,993.85
Retained Earnings / Accumulated Deficit-2,030.84
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-37.00
Total Stockholder's Equity-37.00
Liabilities & Stockholder's Equity21.02
4 historic quarters locked

Sign in to unlock the full Atara Biotherapeutics Inc balance sheet history.

About Atara Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-346885

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.